Position in ANNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,620,890
-$394,532 QoQ
Shares Held
459,000
-15.7% QoQ
Ownership
0.225%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 216 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. ANNX ranks #114 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ANNX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,620,890 | 459,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,015,422 | 544,300 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,029,052 | 802,600 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,298,415 | 753,579 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,866,960 | 777,900 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,243,503 | 1,162,437 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,532,681 | 493,700 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,376,288 | 401,400 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,862,580 | 584,200 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,812,504 | 671,200 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,198,268 | 484,200 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,324,691 | 561,310 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,486,144 | 422,200 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,374,835 | 357,100 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,603,217 | 310,100 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,040,636 | 330,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,356,823 | 359,900 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,628,524 | 596,529 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,159,341 | 100,900 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||